We’re excited to join the European Respiratory Society Annual Meeting alongside the scientific and patient community to share insights about advances in cystic fibrosis. Visit us at Booth C7.02 and learn more about our work: www.vrtx.com/our-science
Exciting times ahead at the European Respiratory Society Annual Meeting! Looking forward to the insights and advancements in cystic fibrosis care. Be sure to visit Booth C7.02 to learn more about the impactful work being done! #CysticFibrosis #ERS2024 #AdvancingScience
🙌🏼
Client Solution Director @ ClinChoice | Patient Advocacy | Patientcentricity | Diversity & Inclusion
2moGreat event. I was at your booth last year, asking for information. This year will you be able to disclose any information about EMA review of MAA Extension for Kaftrio to include people with CF and responsive rare mutations ? The application was done in November '23 and, patients, like my son with double N1303K mutation, are still waiting. But CF is not waiting and patients are getting worse and worse, with a drug already available that could really reverse their symptoms. In US is already used since more than a year. Where is #equity in treatments? Is @EMA doing cuddles to the dossier ?